Clinical Trial Update: Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) [Phase 1]

View source ↗

Summary

Phase 1 study to assess the effect of food on the pharmacokinetics, pharmacodynamics, and safety of CKD-519 FDI in individuals with dyslipidemia; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• CKD-519 FDI (CKD-519)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED